Screener
Roivant Sciences ROIV Increase (Decrease) In Litigation Settlement Receivables
Increase (Decrease) In Litigation Settlement Receivables at other companies
Other financials
Where this comes from
Reported directly by Roivant Sciences in its filing.
Tagged under the XBRL concept roiv:IncreaseDecreaseInLitigationSettlementReceivables.
The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001635088-26-000090
FAQ
- What is Roivant Sciences's increase (decrease) in litigation settlement receivables?
- Roivant Sciences (ROIV) reported increase (decrease) in litigation settlement receivables of $1.39M in Q2 2026.
- What does increase (decrease) in litigation settlement receivables mean?
- This tracks the change in receivables arising from legal settlements owed to the company. It represents the cash flow impact of recognizing or collecting on legal claims and settlements.
Ask your AI about Roivant Sciences's increase (decrease) in litigation settlement receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude